Ovarian stimulation for IVF/ICSI cycles: A pharmacogenomic approach

Medecine Therapeutique Medecine de la Reproduction, Gynecologie et Endocrinologie

Volumn 11, Issue 4, 2009, Pages 271-277

  Alviggi, C ^a   Conforti, A ^a   Fabozzi, F ^a   De Placido, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ART IVF; Ovarian stimulation; Pharmacogenomics; Poor responders

Indexed keywords

EID: 70349243211     PISSN: 1774640X     EISSN: None     Source Type: Journal    
DOI: 10.1684/mte.2009.0255     Document Type: Article

References (25)

1. Alviggi C, Clarizia R, Pettersson K, et al. Suboptimal response to GnRH-a long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2009a; 18: 9-14.
2. Alviggi C, Clarizia R, Pettersson K, et al. Mutation LH beta subunit is associated with higher exogenous FSH consumption of FSH during ovarian stimulation. Hum Reprod 2009b; 24(Suppl. 1): O-077, i31.
3. 3. Behre HM, Greb RR, Mempel A, et al. Significance of a common single nucleotide polymorphism in exon 10 of the folliclestimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005; 15: 451-456 (Pubitemid 41017593)
4. 4. De Placido G, Mollo A, Alviggi C, et al. Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum Reprod 2001; 16: 1875-1879 (Pubitemid 32916215)
5. 5. De Placido G, Alviggi C, Mollo A, et al. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol (Oxf) 2004; 60: 637-643 (Pubitemid 38669856)
6. 6. De Placido G, Alviggi C, Peřino A, et al. Recombinant human LH supplementation vs recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005; 20: 390-396 (Pubitemid 40277606)
7. Devroey P, Fauser BC, Diedrich K, Evian Annual Reproduction (EVAR) Workshop Group. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update 2008; 15: 391-408.
8. 8. Erickson GF, Wang C, Hsueh AJW. FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature 1979; 279: 336-338 (Pubitemid 9179037)
9. 9. Ferraretti AP, Gianaroli L, Magii MC, et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004; 82: 1521-1526 (Pubitemid 39611376)
10. Fevold H. Synergysm of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinol 1941; 28: 33-36
11. 11. Filicori M, Cognigni GE, Pocognoli P, et al. Current concepts and novel applications of LH activity in ovarian stimulation. Trends Endocrinol Metab 2003; 14: 267-273 (Pubitemid 36988440)
12. 12. Greb RR, Grieshaber K, Gromoll J, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005; 90: 4866-4872 (Pubitemid 41159384)
13. Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the "two-cell, two-gonadotrophin" model revisited. Mol Cellular Endocrinol 1994; 100: 51-54
14. 14. Huang ZH, Clayton PE, Brady G, et al. Insulin-like growth factor-l gene expression in human granulosa-lutein cells. IMoI Endocrinol 1994; 12: 283-291 (Pubitemid 24199698)
15. Lisi F, Rinaldi L, Fishel S, et al. Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reprod Biomed Online 2001; 3: 190-194
16. Mochtar MH, Van der Veen, Ziech M, van Wely M. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007; 2: CD005070.
17. Pellicer A, Miro F, Sampaio M, et al. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20desmolase deficiency. Fertil Steril 1991; 55: 970-975
18. 18. Perez Mayorga M, Gromoll J, Behre HM, et al. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. I Clin Endocrinol Metab 2000; 85: 3365-3369 (Pubitemid 30944552)
19. 19. Pettersson K, Söderholm JR. Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. Clin Chemi 1991;37:333-340 (Pubitemid 21892651)
20. 20. Rabinovici J, Blankstein J, Goldman B, et al. In vitro fertilization and primary embryonic cleavage are possible in 17 alphahydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Clin Endocrinol Metab 1989; 68: 693-697 (Pubitemid 19081449)
21. 21.Shetty G, Krishnamurthy H, Krishnamurthy HN, et al. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol 1997; 61: 57-66. (Pubitemid 27455674)
22. 22. Shima K, Kitayama S, Nakano R. Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstet Gynecol 1987; 69: 800-806 (Pubitemid 17057846)
23. Zelezník AJ, Hillier SG. The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol 1984; 27: 927-940
24. 24. Zelinski-Wooten MB, Hess DL, Baughman WL, et al. Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function. J Clin Endocrinol Metab 1993; 76: 988-995 (Pubitemid 23110850)
25. 25. Zhou J, Bondy C. Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod 1993; 48: 467-482 (Pubitemid 23056009)